Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Shenzhen Hepalink IPO Creates China’s Wealthiest Couple

publication date: May 5, 2010
Shenzhen Hepalink Pharmaceutical Co., Ltd. will stage an IPO on the Shenzhen exchange, raising 5.9 billion RMB ($868 million). The IPO price of 148 RMB ($21.62) set a record as the highest IPO price in China's A-share market. Hepalink is the world’s largest producer of heparin, a blood thinner that is harvested from pigs’ intestines. The event made the founders of the company, a couple named Li Li and Li Tan, the richest couple in China, with a stake in Hepalink that is now worth 40.7 billion RMB ($6 billion).  More details...



Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here